Cellectar Biosciences, Inc.CLRBEarnings & Financial Report
Nasdaq
NextMar 30, 2026
CLRB Q3 2025 Key Financial Metrics
Revenue
$0
Gross Profit
N/A
Operating Profit
$-4.9M
Net Profit
$-4.4M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
EPS
$-1.41
Cellectar Biosciences, Inc. Q3 2025 Financial Summary
Cellectar Biosciences, Inc. reported revenue of $0 for Q3 2025, with a net profit of $-4.4M (N/A margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $0 |
|---|---|
| Net Profit | $-4.4M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q3 2025 |
Cellectar Biosciences, Inc. Annual Revenue by Year
Cellectar Biosciences, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $0).
| Year | Annual Revenue |
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $0 |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $12.1M | $42.9M | $29.4M | $37.3M | $25.5M | $16.0M | $13.7M | $14.6M |
| Liabilities | $13.4M | $16.7M | $15.6M | $20.7M | $9.8M | $6.4M | $6.2M | $5.2M |
| Equity | $-1.4M | $26.2M | $12.4M | $15.2M | $14.3M | $8.3M | $6.1M | $8.0M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-9.6M | $-13.4M | $-14.1M | $-9.2M | $-10.9M | $-9.4M | $-5.1M | $-4.3M |